BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11503324)

  • 1. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Knol A
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478-9. PubMed ID: 11503324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478. PubMed ID: 11503323
    [No Abstract]   [Full Text] [Related]  

  • 3. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 5. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of acetylsalicylic acid in IHD].
    Lenkovsky F; Neirinck LG; Glezer SV
    Ter Arkh; 1996; 68(8):79-83. PubMed ID: 9019841
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

  • 9. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B; Renner B; Brune K
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and cyclooxygenase-2 inhibitors.
    Armstrong TA
    Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
    [No Abstract]   [Full Text] [Related]  

  • 12. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCX-4016 NicOx.
    Di Napoli M; Papa F
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1126-39. PubMed ID: 14582459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversies in COX-2 selective inhibition.
    Simon LS; Smolen JS; Abramson SB; Appel G; Bombardier C; Brater DC; Breedveld FC; Brune K; Burmester GR; Crofford LJ; Dougados M; DuBois RN; Fitzgerald GA; Frishman W; García Rodríguez LA; Hochberg MC; Kalden JR; Laine L; Langman MJ; Prescott SM; van de Putte LB; Whelton A; White WB; Willaims GH
    J Rheumatol; 2002 Jul; 29(7):1501-10. PubMed ID: 12136912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 17. [Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary].
    van den Broek JA; van Duijnhoven JL
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):469; author reply 469. PubMed ID: 12666521
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
    Hennekens CH; Sechenova O; Hollar D; Serebruany VL
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
    Fisher M; Knappertz V
    Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
    [No Abstract]   [Full Text] [Related]  

  • 20. What price pain relief?
    Hochman JS; Shah NR
    Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.